CGEN(Compugen Ltd.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $6.00M | $7.50M | $33.46M | $27.86M | $72.76M |
| 毛利润 | $5.32M | $6.53M | $31.45M | $19.93M | $63.51M |
| 营业利润 | −$35.07M | −$35.37M | −$12.99M | −$14.89M | $31.33M |
| 净利润 | −$34.20M | −$33.69M | −$18.75M | −$14.23M | $35.34M |
| 经营现金流 | −$22.69M | −$34.11M | −$35.89M | $49.60M | $31.63M |
| 自由现金流 | −$22.98M | −$34.59M | −$36.06M | $49.49M | $31.33M |
| 摊薄每股收益 | $-0.41 | $-0.39 | $-0.21 | $-0.16 | $0.38 |